Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics Gets New Methylation Technologies, Adds Two to SAB

NEW YORK, Jan. 27-Berlin-based Epigenomics has secured rights to DNA methylation research from Johns Hopkins University and to a DNA-based tumor detection method from the Australian Commonwealth Scientific and Industrial Research Organization, the company said today.

 

Johns Hopkins University granted the company an exclusive worldwide license to a set of methods to detect cancer through genomic imprinting, an epigenetic phenomenon in which parental origin controls gene expression. JHU's Andrew Feinberg has studied the loss of imprinting in cancer, identifying CpG-rich areas of the genome that are unmethylated in cancerous cells. Epigenomics will use this knowledge to try to develop assays that detect the disease at early stages. Feinberg has also joined the company's scientific advisory board.

 

From the Australian CSIRO's Division of Molecular Science, the company has obtained an option agreement for the research institute's "headloop" assay that distinguishes tumor DNA from normal DNA in the blood.

 

The CSIRO's Susan Clark, who has developed a method to detect methylation in DNA, has also joined the company's board of scientific advisors.

 

Epigenomics is focused on developing methylation detection technologies for the early stage detection of cancer. It has a subsidiary in Seattle, Wash.

 

For further information, see the company news release.

 

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.